Stewart Kroll

Stewart Kroll

Corporate Officer/Principal chez AURINIA PHARMACEUTICALS INC.
67 ans
Health Technology
Consumer Services
Technology Services

Profil

Stewart M.
Kroll
is Chief Development Officer at Aurinia Pharmaceuticals, Inc. Former positions include Chief Development Officer at La Jolla Pharmaceutical Co. from 2020 to 2022, Chief Development Officer at Odonate, Inc. from 2018 to 2021, Senior Vice President at Biometrics, Inc. from 2017 to 2019, Chief Operating Officer at Threshold Pharmaceuticals, Inc. in 2016, Senior Director-Biostatistics at Corixa Corp.
from 2000 to 2005, and Director-Biostatistics at Coulter Pharmaceuticals, Inc. from 1997 to 2000.
Education includes undergraduate and graduate degrees from the University of California, Berkeley.

Postes actifs de Stewart Kroll

SociétésPosteDébut
AURINIA PHARMACEUTICALS INC. Corporate Officer/Principal -

Anciens postes connus de Stewart Kroll

SociétésPosteFin
LA JOLLA PHARMACEUTICAL COMPANY Corporate Officer/Principal 01/09/2022
ODONATE, INC. Corporate Officer/Principal 01/10/2021
Corporate Officer/Principal 01/01/2019
Directeur des opérations 30/09/2016
Corporate Officer/Principal 01/01/2005
Voir l'expérience en détail de Stewart Kroll

Formation de Stewart Kroll

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

72

Relations au 1er degré

8

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées8

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Technology Services

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Stewart Kroll